Centre plans bulk drug PLI scheme revamp, says pharmaceuticals secretary Manoj Joshi
India’s reliance on imports for certain critical classes of drugs creates strategic vulnerabilities by exposing the pharmaceutical supply chain to external disruptions and geopolitical risks.
Post Comment